Free Trial

Sensata Technologies (ST) Competitors

$38.23
+0.98 (+2.63%)
(As of 07/26/2024 ET)

ST vs. AVTR, BIO.B, OLK, TRNS, LAB, CTKB, QTRX, EYPT, NAUT, and SENS

Should you be buying Sensata Technologies stock or one of its competitors? The main competitors of Sensata Technologies include Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Olink Holding AB (publ) (OLK), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Quanterix (QTRX), EyePoint Pharmaceuticals (EYPT), Nautilus Biotechnology (NAUT), and Senseonics (SENS). These companies are all part of the "measuring and control equipment" industry.

Sensata Technologies vs.

Sensata Technologies (NYSE:ST) and Avantor (NYSE:AVTR) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings.

In the previous week, Avantor had 13 more articles in the media than Sensata Technologies. MarketBeat recorded 23 mentions for Avantor and 10 mentions for Sensata Technologies. Sensata Technologies' average media sentiment score of 0.80 beat Avantor's score of 0.69 indicating that Sensata Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sensata Technologies
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
10 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sensata Technologies has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Avantor has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.

Sensata Technologies currently has a consensus target price of $44.90, suggesting a potential upside of 17.45%. Avantor has a consensus target price of $25.93, suggesting a potential upside of 1.32%. Given Sensata Technologies' higher probable upside, equities research analysts plainly believe Sensata Technologies is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensata Technologies
1 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
Avantor
0 Sell rating(s)
5 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.69

Sensata Technologies received 268 more outperform votes than Avantor when rated by MarketBeat users. However, 63.81% of users gave Avantor an outperform vote while only 62.27% of users gave Sensata Technologies an outperform vote.

CompanyUnderperformOutperform
Sensata TechnologiesOutperform Votes
439
62.27%
Underperform Votes
266
37.73%
AvantorOutperform Votes
171
63.81%
Underperform Votes
97
36.19%

Avantor has higher revenue and earnings than Sensata Technologies. Sensata Technologies is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensata Technologies$4.05B1.42-$3.91M-$0.11-347.51
Avantor$6.97B2.49$321.10M$0.3965.62

Avantor has a net margin of 3.79% compared to Sensata Technologies' net margin of -0.35%. Sensata Technologies' return on equity of 17.58% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Sensata Technologies-0.35% 17.58% 6.80%
Avantor 3.79%13.01%5.22%

99.4% of Sensata Technologies shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 1.0% of Sensata Technologies shares are owned by insiders. Comparatively, 1.5% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Avantor beats Sensata Technologies on 12 of the 18 factors compared between the two stocks.

Get Sensata Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ST vs. The Competition

MetricSensata TechnologiesProcess control instruments IndustryComputer SectorNYSE Exchange
Market Cap$5.75B$21.74B$22.19B$18.49B
Dividend Yield1.29%1.00%2.70%3.51%
P/E Ratio-347.5127.10271.0325.43
Price / Sales1.425.07609.8215.35
Price / Cash4.7517.6031.7119.61
Price / Book1.933.696.895.08
Net Income-$3.91M$459.04M$637.08M$977.27M
7 Day Performance-1.70%-0.17%0.69%1.57%
1 Month Performance2.60%4.71%3.58%5.69%
1 Year Performance-8.58%8.31%12.57%9.05%

Sensata Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
4.2901 of 5 stars
4.29 / 5 stars
$20.85
+0.5%
$25.93
+24.4%
+9.6%$14.16B$6.97B53.4614,500Options Volume
News Coverage
Gap Up
BIO.B
Bio-Rad Laboratories
0 of 5 stars
0.00 / 5 stars
$294.23
+3.8%
N/A-24.1%$8.39B$2.67B-28.408,200Upcoming Earnings
News Coverage
OLK
Olink Holding AB (publ)
0.3207 of 5 stars
0.32 / 5 stars
$26.08
+0.3%
$26.00
-0.3%
+37.5%$3.24B$170.89M-96.59420High Trading Volume
TRNS
Transcat
2.2212 of 5 stars
2.22 / 5 stars
$136.85
-0.1%
$142.67
+4.3%
+66.4%$1.25B$259.48M86.071,104Upcoming Earnings
News Coverage
High Trading Volume
LAB
Standard BioTools
2.6658 of 5 stars
2.67 / 5 stars
$2.19
+0.5%
$3.38
+54.1%
+0.0%$811.22M$126.76M-2.17620Upcoming Earnings
Short Interest ↑
News Coverage
CTKB
Cytek Biosciences
1.8494 of 5 stars
1.85 / 5 stars
$6.15
-3.6%
$8.63
+40.2%
-25.2%$807.33M$200.79M-68.33500News Coverage
QTRX
Quanterix
1.2895 of 5 stars
1.29 / 5 stars
$14.40
-3.6%
$28.60
+98.6%
-33.7%$551.09M$122.37M-15.00460Gap Up
EYPT
EyePoint Pharmaceuticals
2.991 of 5 stars
2.99 / 5 stars
$8.80
-0.6%
$33.29
+278.2%
-4.9%$458.30M$46.02M-4.84120Gap Up
NAUT
Nautilus Biotechnology
1.863 of 5 stars
1.86 / 5 stars
$2.61
-3.3%
$5.00
+91.6%
-5.8%$326.94MN/A-4.75130Upcoming Earnings
SENS
Senseonics
1.5153 of 5 stars
1.52 / 5 stars
$0.47
+3.1%
$2.00
+329.2%
N/A$247.40M$22.39M-3.3390Analyst Forecast
News Coverage

Related Companies and Tools

This page (NYSE:ST) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners